Interpregnancy Interval and Birth Outcomes: A Propensity Matching Study in the California Population.


Journal

Maternal and child health journal
ISSN: 1573-6628
Titre abrégé: Matern Child Health J
Pays: United States
ID NLM: 9715672

Informations de publication

Date de publication:
May 2022
Historique:
accepted: 12 02 2022
pubmed: 10 3 2022
medline: 26 4 2022
entrez: 9 3 2022
Statut: ppublish

Résumé

Previous studies that used traditional multivariable and sibling matched analyses to investigate interpregnancy interval (IPI) and birth outcomes have reached mixed conclusions about a minimum recommended IPI, raising concerns about confounding. Our objective was to isolate the contribution of interpregnancy interval to the risk for adverse birth outcomes using propensity score matching. For this retrospective cohort study, data were drawn from a California Department of Health Care Access and Information database with linked vital records and hospital discharge records (2007-2012). We compared short IPIs of < 6, 6-11, and 12-17 months to a referent IPI of 18-23 months using 1:1 exact propensity score matching on 13 maternal sociodemographic and clinical factors. We used logistic regression to calculate the odds of preterm birth, early-term birth, and small for gestational age (SGA). Of 144,733 women, 73.6% had IPIs < 18 months, 5.5% delivered preterm, 27.0% delivered early-term, and 6.0% had SGA infants. In the propensity matched sample (n = 83,788), odds of preterm birth were increased among women with IPI < 6 and 6-11 months (OR 1.89, 95% CI 1.71-2.0; OR 1.22, 95% CI 1.13-1.31, respectively) and not with IPI 12-17 months (OR 1.01, 95% CI 0.94-1.09); a similar pattern emerged for early-term birth. The odds of SGA were slightly elevated only for intervals < 6 months (OR 1.10, 95% CI 1.00-1.20, p < .05). This study demonstrates a dose response association between short IPI and adverse birth outcomes, with no increased risk beyond 12 months. Findings suggest that longer IPI recommendations may be overly proscriptive.

Identifiants

pubmed: 35260953
doi: 10.1007/s10995-022-03388-4
pii: 10.1007/s10995-022-03388-4
pmc: PMC9023393
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1115-1125

Subventions

Organisme : NICHD NIH HHS
ID : K12 HD052163
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Paediatr Perinat Epidemiol. 2019 Jan;33(1):O25-O47
pubmed: 30353935
Pediatrics. 2014 May;133(5):844-53
pubmed: 24777216
BJOG. 2015 Oct;122(11):1484-93
pubmed: 26111589
J Perinatol. 2017 Feb;37(2):144-149
pubmed: 27735928
BJOG. 2016 Nov;123(12):2009-2017
pubmed: 27405702
JAMA. 2006 Apr 19;295(15):1809-23
pubmed: 16622143
MMWR Recomm Rep. 2014 Apr 25;63(RR-04):1-54
pubmed: 24759690
Contraception. 2015 Jun;91(6):433-7
pubmed: 25677992
Soc Sci Med. 2016 Mar;153:156-64
pubmed: 26900890
J Urban Health. 2019 Apr;96(2):159-170
pubmed: 29869317
Matern Child Health J. 2011 Feb;15(2):205-16
pubmed: 20012348
Am J Obstet Gynecol. 2017 Feb;216(2):129-134
pubmed: 27776920
Lancet. 2008 Jan 5;371(9606):75-84
pubmed: 18177778
Obstet Gynecol. 2017 Mar;129(3):405-407
pubmed: 28178065
Am J Obstet Gynecol. 2014 Dec;211(6):675.e1-19
pubmed: 24949541
Am J Obstet Gynecol MFM. 2019 Nov;1(4):100053
pubmed: 33345843
Obstet Gynecol. 2016 Aug;128(2):364-372
pubmed: 27400000
Obstet Gynecol. 2013 Jul;122(1):64-71
pubmed: 23743455
Natl Vital Stat Rep. 2019 Nov;68(13):1-47
pubmed: 32501202
Paediatr Perinat Epidemiol. 2019 Jan;33(1):O48-O59
pubmed: 30311955
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
BJOG. 2014 Dec;121(13):1633-40
pubmed: 24893887
Womens Health Issues. 2018 Sep - Oct;28(5):408-414
pubmed: 30143419
Hum Reprod Update. 2012 Jan-Feb;18(1):29-43
pubmed: 21989171
Paediatr Perinat Epidemiol. 2019 Jan;33(1):O15-O24
pubmed: 30311958
Paediatr Perinat Epidemiol. 2019 Jan;33(1):O1-O4
pubmed: 30346060
Perspect Sex Reprod Health. 2014 Sep;46(3):171-5
pubmed: 24861029
Matern Child Health J. 2013 Jul;17(5):933-9
pubmed: 22791206
Epidemiology. 2002 Nov;13(6):646-52
pubmed: 12410005
Am J Obstet Gynecol. 2019 Jan;220(1):B2-B18
pubmed: 30579872
J Matern Fetal Neonatal Med. 2017 Nov;30(21):2640-2644
pubmed: 27903080

Auteurs

Jayme L Congdon (JL)

Department of Pediatrics, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA. jayme.congdon@ucsf.edu.

Rebecca J Baer (RJ)

Department of Pediatrics, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA, 92093, USA.
California Preterm Birth Initiative, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA.

Jennet Arcara (J)

Sexual Health and Reproductive Equity Program, School of Social Welfare, University of California, Berkeley, 120 Haviland Hall #7400, Berkeley, CA, 94720-7400, USA.

Sky K Feuer (SK)

California Preterm Birth Initiative, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA.
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA.

Anu Manchikanti Gómez (AM)

Sexual Health and Reproductive Equity Program, School of Social Welfare, University of California, Berkeley, 120 Haviland Hall #7400, Berkeley, CA, 94720-7400, USA.

Deborah Karasek (D)

California Preterm Birth Initiative, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA.
Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA.

Scott P Oltman (SP)

California Preterm Birth Initiative, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA.
Department of Epidemiology and Biostatistics, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA.

Matthew S Pantell (MS)

Department of Pediatrics, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA.

Kelli Ryckman (K)

Departments of Epidemiology and Pediatrics, University of Iowa, 145 N. Riverside Drive, Iowa City, IA, 52242, USA.

Laura Jelliffe-Pawlowski (L)

California Preterm Birth Initiative, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA.
Department of Epidemiology and Biostatistics, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH